- Trials with a EudraCT protocol (303)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (13)
303 result(s) found for: Cerebrospinal fluid.
Displaying page 1 of 16.
EudraCT Number: 2019-001863-60 | Sponsor Protocol Number: 04/2019 | Start Date*: 2019-08-30 |
Sponsor Name:Abteilung für Hals-, Nasen- und Ohrenkrankheiten MUW, AKH Wien | ||
Full Title: Cerebrospinal fluid levels of triamcinolone acetonide | ||
Medical condition: In this study triamcinolone acetonide levels after intratympanic application in the cerebrospinal fluid will be studied. Patients undergoing surgery with dura access will be asked to participate. P... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-002377-19 | Sponsor Protocol Number: 1456/2017 | Start Date*: 2017-09-15 |
Sponsor Name:Abteilung für Hals-, Nasen- und Ohrenkrankheiten MUW, AKH Wien | ||
Full Title: Triamcinolone levels in cochlear perilymph | ||
Medical condition: In this study triamcinolone acetonide levels after intratympanic application in the perilymph, and serum of patients receiving a cochlear implant will be studied. In patients undergoing a translaby... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-005535-40 | Sponsor Protocol Number: 3599-001 | Start Date*: 2016-07-21 | |||||||||||
Sponsor Name:Baxter Healthcare Corporation | |||||||||||||
Full Title: A Randomised Controlled Study to Evaluate the Efficacy and Safety of Fibrin Sealant, Vapour Heated, Solvent/Detergent Treated (FS VH S/D 500 s-apr) Compared to DuraSeal Dural Sealant as an Adjunct ... | |||||||||||||
Medical condition: Intra-operative CSF leak | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) ES (Completed) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019488-12 | Sponsor Protocol Number: Protocol No 1 | Start Date*: 2010-12-08 |
Sponsor Name:Joint Research Office, Barts and The London NHS Trust | ||
Full Title: A Single Centre Prospective Randomised Study to Investigate the Metabolism of Intravenous Paracetamol in Humans | ||
Medical condition: The study is looking at the cerebrospinal fluid pharmacokinetics of intravenous paracetamol. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-005542-42 | Sponsor Protocol Number: 2020/11 | Start Date*: 2021-03-11 |
Sponsor Name:Region Västerbotten | ||
Full Title: Intrathecal contrast-enhanced MRI for investigation of cerebrospinal fluid transportation | ||
Medical condition: Cerebrospinal fluid circulation disorder seen in clinically suspected idiopathic normal pressure hydrocephalus | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004097-17 | Sponsor Protocol Number: MEMANTINE001 | Start Date*: 2017-04-07 | |||||||||||
Sponsor Name:Fakultni nemocnice Hradec Kralove | |||||||||||||
Full Title: Evaluation of changes in concentrations of memantine in the cerebrospinal fluid of patients with Alzheimer´s disease. | |||||||||||||
Medical condition: Alzheimer's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001447-31 | Sponsor Protocol Number: 954 | Start Date*: 2014-01-14 |
Sponsor Name:Liverpool Heart and Chest Hospital NHS Foundation Trust | ||
Full Title: A randomised controlled trial to study the effect of acetazolamide on the incidence of blood-stained CSF, effect on cerebrospinal fluid (CSF) pressure, CSF drainage and neurological dysfunction in ... | ||
Medical condition: Elevated cerebrospinal fluid pressure in patients undergoing thoracic-abdominal aortic repair | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004427-31 | Sponsor Protocol Number: TAFCNS2015 | Start Date*: 2016-03-07 |
Sponsor Name:Gothenburg University | ||
Full Title: Tenofovir Alafenamide Fumarate (TAF) effect on residual intrathecal immune activation | ||
Medical condition: HIV-infection in the central nervous system | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004414-10 | Sponsor Protocol Number: TERIFL08519 | Start Date*: 2018-02-23 |
Sponsor Name:MS Centrum, Department of Neurology, Sshlgrenska University Hospital | ||
Full Title: Determination of the concentration of Teriflunomide in serum and cerebrospinal fluid from patients with multiple sclerosis who are treated with Teriflunomide 14 mg daily. | ||
Medical condition: Multiple Sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000302-39 | Sponsor Protocol Number: IN-ES-380-4475 | Start Date*: 2018-06-18 |
Sponsor Name:Fundació Lluita contra la SIDA | ||
Full Title: Bictegravir concentrations and antiviral activity in cerebrospinal fluid in HIV-1 Infected individuals | ||
Medical condition: HIV-1 infected individuals | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-001795-37 | Sponsor Protocol Number: AMB TS | Start Date*: 2007-07-19 |
Sponsor Name:Medical University Innsbruck, Dpt. Internal Medicine, Div. Internal Medicine | ||
Full Title: WIRKORTKONZENTRATIONEN VON AMPHOTERICIN B FORMULIERUNGEN IN ASZITES, LIQUOR, PLEURAERGUSS, GALLE UND LIQUOR BEI KRITISCH KRANKEN (Target-site concentrations of Amphotericin B preparations in ascit... | ||
Medical condition: Plasma and target-site (ascites, pleural effusion, bile and cerebrospinal fluid) concentrations of amphotericin B preparations will be measured in critically ill patients, requiring treatment with ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001673-40 | Sponsor Protocol Number: 2015/96 | Start Date*: 2015-06-29 |
Sponsor Name:Oslo University Hospital | ||
Full Title: INTRATHECAL CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING | ||
Medical condition: Cerebrospinal fluid circulation disorder seen in the following clinical disease states: Communicating hydrocephalus, idiopathic intracranial hypertension, idiopathic intracranial hypotension, intra... | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NO (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003586-94 | Sponsor Protocol Number: DONEPEZIL001 | Start Date*: 2018-01-08 | |||||||||||
Sponsor Name:Fakultní nemocnice Hradec Králové | |||||||||||||
Full Title: Monitoring of changes in donepezil concentrations, biomarkers of oxidative stress and activity of acetylchonesterase in the cerebrospinal fluid and plasma of patients with Alzheimer disease. | |||||||||||||
Medical condition: Alzheimer's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003854-80 | Sponsor Protocol Number: 02B2005 | Start Date*: 2006-01-31 |
Sponsor Name:Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University | ||
Full Title: Modulation of the Surgical Inflammatory Response by Etoricoxib: Peripheral versus Central | ||
Medical condition: Patients with osteoarthritis undergoing elective primary single hip arthroplasty | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-005065-38 | Sponsor Protocol Number: ECHI-TS-2 | Start Date*: 2014-02-17 |
Sponsor Name:Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin I | ||
Full Title: Concentrations of echinocandins in ascites, pleural effusion, bile, wound secretion and cerebrospinal fluid – a pilot study | ||
Medical condition: Invasive fungal infection treated with an echinocandin and indication for paracentesis, thoracentesis, bile deviation or sampling, lumbar puncture or VAC therapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000219-14 | Sponsor Protocol Number: 1957 | Start Date*: 2008-03-19 | |||||||||||
Sponsor Name:North Bristol NHS Trust | |||||||||||||
Full Title: Efficacy of 8.4% sodium bicarbonate in adult patients with closed head injuries and intracranial hypertension. | |||||||||||||
Medical condition: Raised intracranial pressure after severe head injury. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000496-64 | Sponsor Protocol Number: SCALA | Start Date*: 2014-04-23 |
Sponsor Name:Dr. Daniel Podzamczer Palter. Hospital Univesitari de Bellvitge. Unidad de VIH. | ||
Full Title: Viral suppression in Cerebrospinal Fluid in HIV-1 infected patients receiving Ritonavir-boosted Atazanavir plus lamivudine dual theraphy. SCALA study | ||
Medical condition: HIV-1 infection | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022085-26 | Sponsor Protocol Number: rhLAMAN-03 | Start Date*: 2010-10-05 |
Sponsor Name:Zymenex A/S | ||
Full Title: A single center, randomized, open-label, multiple-dose study of the efficacy and long-term safety of rhLAMAN (recombinant human alpha-mannosidase or Lamazym) for the treatment of patients with alph... | ||
Medical condition: Treatment of alpha-Mannosidosis | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-018920-21 | Sponsor Protocol Number: ZICBOL2010 | Start Date*: 2011-03-23 | |||||||||||
Sponsor Name:Landstinget i Östergötland | |||||||||||||
Full Title: Evaluation of a Structured Algorithm for Intrathecal Bolus Doses of Ziconotide(Prialt®) - The Swedish Ziconotide Bolus Study | |||||||||||||
Medical condition: Chronic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003032-23 | Sponsor Protocol Number: AADC-010 | Start Date*: 2019-10-09 |
Sponsor Name:National Taiwan University Hospital | ||
Full Title: A Phase I/II Clinical Trial for Treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC | ||
Medical condition: Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
